Gene · 1200
Papers2,632
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,632
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Evidence of the impact of CLN2 and CLN3 Batten disease on families in the United Kingdom. | Orphanet J Rare Dis | 2025 | 40355884 | PubTator, text mining | PubMed |
| A novel splicing graph allows a direct comparison between exon-based and splice junction-based approaches to alternative splicing detection. | Brief Bioinform | 2025 | 40341920 | PubTator, text mining | PubMed |
| Cerebrospinal fluid proteome profiling across the Alzheimer's disease continuum: a step towards solving the equation for 'X'. | Mol Neurodegener | 2025 | 40329321 | PubTator, text mining | PubMed |
| Novel surgical approach for intraventricular cerliponase alfa enzyme replacement therapy via central venous access device (CVAD) port in neuronal ceroid lipofuscinosis type 2 (CLN2) disease. | Childs Nerv Syst | 2025 | 40295329 | PubTator, text mining | PubMed |
| C1Q+ TPP1+ macrophages promote colon cancer progression through SETD8-driven p53 methylation. | Mol Cancer | 2025 | 40165182 | PubTator, text mining | PubMed |
| Enzyme Replacement Therapy in CLN2-Associated Retinopathy. | Klin Monbl Augenheilkd | 2025 | 40127655 | PubTator, text mining | PubMed |
| Calcium modulating ligand confers risk for Parkinson's disease and impacts lysosomes. | Ann Clin Transl Neurol | 2025 | 40053464 | PubTator, text mining | PubMed |
| The relationship between telomere length and aging-related diseases. | Clin Exp Med | 2025 | 40044947 | PubTator, text mining | PubMed |
| Mendelian randomization identifies proteins involved in neurodegenerative diseases. | Brain | 2025 | 40037332 | PubTator, text mining | PubMed |
| The canonical RPA complex interacts with Est3 to regulate yeast telomerase activity. | Proc Natl Acad Sci U S A | 2025 | 39913192 | PubTator, text mining | PubMed |
| Intravitreal Enzyme Replacement Therapy Slows Retinopathy in Late Infantile Ceroid Lipofuscinosis Type 2. | Neuropediatrics | 2025 | 39776429 | PubTator, text mining | PubMed |
| Two-year follow-up of gait and postural control following initiation of recombinant human tripeptidyl intracerebroventricular enzyme replacement therapy in two atypical CLN2 patients. | Sci Rep | 2025 | 39762319 | PubTator, text mining | PubMed |
Clinical, Pathological, and Molecular Findings in a Mexican Patient With Neuronal Ceroid Lipofuscinosis Type 2: Support for Pathogenicity of the c.1226 G>T Variant and for Presence of Cherry-Red Spot in This Disease. | Pediatr Dev Pathol | 2025 | 39716776 | PubTator, text mining | PubMed |
| Genetic spectrum of neuronal ceroid lipofuscinosis & its genotype-phenotype correlation -A single centre experience of 56 cases. | J Neurol Sci | 2025 | 39675099 | PubTator, text mining | PubMed |
| α/β Hydrolases: Toward Unraveling Entangled Classification. | Proteins | 2025 | 39623291 | PubTator, text mining | PubMed |
| Genetic Reasons for Phenotypic Diversity in Neuronal Ceroid Lipofuscinoses and High-Resolution Imaging as a Marker of Retinal Disease. | Ophthalmol Sci | 2024 | 40206986 | PubTator, text mining | PubMed |
| Twenty-Year Survival Analysis of Adeno-Associated Virus Vector Serotype 2-Mediated Gene Therapy to the Central Nervous System for CLN2 Disease. | Hum Gene Ther | 2024 | 39745261 | PubTator, text mining | PubMed |
| Analysis of immune cell activation in patients with diabetes foot ulcer from the perspective of single cell. | Eur J Med Res | 2024 | 39702546 | PubTator, text mining | PubMed |
| Adverse Reactions to the Orphan Drug Cerliponase Alfa in the Treatment of Neurolipofuscinosis Type 2 (CLN2). | Pharmaceuticals (Basel) | 2024 | 39598424 | PubTator, text mining | PubMed |
| Combatting cellular immortality in cancers by targeting the shelterin protein complex. | Biol Direct | 2024 | 39578854 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1200/papers?page=4